BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26433667)

  • 1. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Crum C; Friedlander M
    Int J Gynaecol Obstet; 2015 Oct; 131 Suppl 2():S111-22. PubMed ID: 26433667
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Crum C; Friedlander M
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S118-29. PubMed ID: 22999503
    [No Abstract]   [Full Text] [Related]  

  • 3. Staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J;
    Int J Gynaecol Obstet; 2014 Jan; 124(1):1-5. PubMed ID: 24219974
    [No Abstract]   [Full Text] [Related]  

  • 4. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J;
    Eur J Obstet Gynecol Reprod Biol; 2015 May; 188():133-5. PubMed ID: 25819291
    [No Abstract]   [Full Text] [Related]  

  • 5. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Abridged Republication of Guidelines From the International Federation of Gynecology and Obstetrics (FIGO).
    Prat J;
    Obstet Gynecol; 2015 Jul; 126(1):171-4. PubMed ID: 26241270
    [No Abstract]   [Full Text] [Related]  

  • 7. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.
    Prat J;
    J Gynecol Oncol; 2015 Apr; 26(2):87-9. PubMed ID: 25872889
    [No Abstract]   [Full Text] [Related]  

  • 8. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J; Belhadj H; Berek J; Bermudez A; Bhatla N; Cain J; Denny L; Fujiwara K; Hacker N; Avall-Lundqvist E; Mutch D; Odicino F; Pecorelli S; Quinn M; Seoud MA; Shrivastava SK;
    Eur J Gynaecol Oncol; 2015; 36(4):367-9. PubMed ID: 26390684
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.
    Goodman MT; Shvetsov YB
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):132-9. PubMed ID: 19124490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer.
    Komiyama S; Katabuchi H; Mikami M; Nagase S; Okamoto A; Ito K; Morishige K; Suzuki N; Kaneuchi M; Yaegashi N; Udagawa Y; Yoshikawa H
    Int J Clin Oncol; 2016 Jun; 21(3):435-46. PubMed ID: 27142770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum.
    Singh N; Gilks CB; Wilkinson N; McCluggage WG
    Histopathology; 2015 Sep; 67(3):331-7. PubMed ID: 25640750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013.
    Prat J
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):858-69. PubMed ID: 25890882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.
    Saida T; Tanaka YO; Matsumoto K; Satoh T; Yoshikawa H; Minami M
    Jpn J Radiol; 2016 Feb; 34(2):117-24. PubMed ID: 26696400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
    Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
    Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
    Jordan SJ; Green AC; Whiteman DC; Moore SP; Bain CJ; Gertig DM; Webb PM; ;
    Int J Cancer; 2008 Apr; 122(7):1598-603. PubMed ID: 18058817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
    Mutch DG; Prat J
    Gynecol Oncol; 2014 Jun; 133(3):401-4. PubMed ID: 24878391
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of peritoneal washing cytology in staging and prognosis of ovarian and fallopian tube neoplasms: a 10-year retrospective analysis.
    Davidson W; Madan R; O'Neil M; Tawfik OW; Fan F
    Ann Diagn Pathol; 2016 Jun; 22():54-7. PubMed ID: 27180061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.
    Einenkel J; Ott R; Handzel R; Braumann UD; Horn LC
    Int J Gynecol Cancer; 2009 Oct; 19(7):1288-97. PubMed ID: 19823067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer.
    Seidman JD; Zhao P; Yemelyanova A
    Gynecol Oncol; 2011 Mar; 120(3):470-3. PubMed ID: 21159368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical recommendations for diagnosing, treatment and monitoring of patients with ovarian cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].
    Matković V; Haller H; Vrdoljak E; Corusić A; Jelavić TB; Strinić T; Karnjus-Begonja R; Barisic D; Tomić S; Kukura V; Ban M; Ranka SP; Matic M; Skalec SL; Topolovec Z; Mrcela M; Zekan J; Fröbe A; Hajredini A; Babic D; Mamula O; Brncić-Fischer A; Vojnović Z; Sundov D; ; ;
    Lijec Vjesn; 2013; 135(9-10):235-41. PubMed ID: 24364199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.